ResearcherAffiliated Hospital of Nantong UniversityNo recent work listed
Guo-Xiong Zhou
Matched on ORCID iD 0009-0004-3590-5966; OpenAlex author ID A5100940779. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper
Papers 4
- Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. Co-author DOI 10.1007/s10637-020-00951-0↗
- Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jcb.27119↗
- Research on the epigenetic modification of pancreatic cancer vaccine. First author PMID 24901123↗
- Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors. Last author DOI 10.1016/j.biopha.2011.06.009↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yihui Fan · 2 shared papers, 2018–2020 · strength 0.20
- Paper Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. DOI 10.1007/s10637-020-00951-0↗
- Paper Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. DOI 10.1002/jcb.27119↗
- Renfang Mao · 2 shared papers, 2018–2020 · strength 0.20
- Paper Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. DOI 10.1007/s10637-020-00951-0↗
- Paper Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. DOI 10.1002/jcb.27119↗
- Hao Chen · 2 shared papers, 2018–2020 · strength 0.20
- Paper Ubiquitin-specific protease 7 is a druggable target that is essential for pancreatic cancer growth and chemoresistance. DOI 10.1007/s10637-020-00951-0↗
- Paper Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma. DOI 10.1002/jcb.27119↗
- Erhao Zhang · 1 shared paper, 2020 · strength 0.11
- Yingcheng Charles Wu · 1 shared paper, 2018 · strength 0.08
- Yue Ming · 1 shared paper, 2018 · strength 0.08
- Xiaorong Zhou · 2 shared papers, 2011–2014 · strength 0.08
- Xiaoling Ding · 2 shared papers, 2011–2014 · strength 0.08
- Wei Cao · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.